Correlation Between SAB Biotherapeutics and Relay Therapeutics
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Relay Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Relay Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Relay Therapeutics, you can compare the effects of market volatilities on SAB Biotherapeutics and Relay Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Relay Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Relay Therapeutics.
Diversification Opportunities for SAB Biotherapeutics and Relay Therapeutics
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and Relay is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Relay Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relay Therapeutics and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Relay Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relay Therapeutics has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Relay Therapeutics go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Relay Therapeutics
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 5.35 times more return on investment than Relay Therapeutics. However, SAB Biotherapeutics is 5.35 times more volatile than Relay Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Relay Therapeutics is currently generating about 0.08 per unit of risk. If you would invest 6.20 in SAB Biotherapeutics on November 2, 2024 and sell it today you would lose (2.22) from holding SAB Biotherapeutics or give up 35.81% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Relay Therapeutics
Performance |
| Timeline |
| SAB Biotherapeutics |
| Relay Therapeutics |
SAB Biotherapeutics and Relay Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Relay Therapeutics
The main advantage of trading using opposite SAB Biotherapeutics and Relay Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Relay Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relay Therapeutics will offset losses from the drop in Relay Therapeutics' long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
| Relay Therapeutics vs. Stoke Therapeutics | Relay Therapeutics vs. Pliant Therapeutics | Relay Therapeutics vs. Black Diamond Therapeutics | Relay Therapeutics vs. Arvinas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |